JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M705782200 on November 8, 2007

J. Biol. Chem., Vol. 283, Issue 5, 2495-2507, February 1, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/5/2495    most recent
M705782200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Haanstra, J. R.
Right arrow Articles by Bakker, B. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haanstra, J. R.
Right arrow Articles by Bakker, B. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Control and Regulation of Gene Expression

QUANTITATIVE ANALYSIS OF THE EXPRESSION OF PHOSPHOGLYCERATE KINASE IN BLOODSTREAM FORM TRYPANOSOMA BRUCEI*Formula

Jurgen R. Haanstra{ddagger}1, Mhairi Stewart§, Van-Duc Luu§, Arjen van Tuijl{ddagger}, Hans V. Westerhoff{ddagger}, Christine Clayton§2, and Barbara M. Bakker{ddagger}23

From the {ddagger}Vrije Universiteit, Biocentrum Amsterdam, De Boelelaan 1085, 1081 HV Amsterdam, The Netherlands, the §Zentrum für Molekulare Biologie der Universität Heidelberg, Im Neuenheimer Feld 282, 69120 Heidelberg, Germany, and the Manchester Centre for Integrative Systems Biology, MIB, SCEAS, the University of Manchester, Manchester M1 7ND, United Kingdom

Isoenzymes of phosphoglycerate kinase in Trypanosoma brucei are differentially expressed in its two main life stages. This study addresses how the organism manages to make sufficient amounts of the isoenzyme with the correct localization, which processes (transcription, splicing, and RNA degradation) control the levels of mRNAs, and how the organism regulates the switch in isoform expression. For this, we combined new quantitative measurements of phosphoglycerate kinase mRNA abundance, RNA precursor stability, trans splicing, and ribosome loading with published data and made a kinetic computer model. For the analysis of regulation we extended regulation analysis. Although phosphoglycerate kinase mRNAs are present at surprisingly low concentrations (e.g. 12 molecules per cell), its protein is highly abundant. Substantial control of mRNA and protein levels was exerted by both mRNA synthesis and degradation, whereas splicing and precursor degradation had little control on mRNA and protein concentrations. Yet regulation of mRNA levels does not occur by transcription, but by adjusting mRNA degradation. The contribution of splicing to regulation is negligible, as for all cases where splicing is faster than RNA precursor degradation.


Received for publication, July 13, 2007 , and in revised form, October 31, 2007.

* This work was supported in part by a Vernieuwingsimpuls (to B. M. B.) from Netherlands Science Organization NWO, by the EC-FP6 program (through BioSim, NucSys, and EC-MOAN), the ESF program funcdyn, NWO-ALW and NWO-CLS, and by the Biotechnology and Biological Sciences Research Council (to H. V. W.). Work in the Clayton laboratory was supported by the Wellcome Trust (to M. S.) and the Deutsche Forschungsgemeinschaft. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Table 3B, discussion of Table 5, and additional references.

1 Recipient of a VU-FALW Rijnland fonds travel grant for a visit of six months to the Zentrum für Molekulare Biologie der Universität Heidelberg.

2 Both authors contributed equally to this manuscript.

3 To whom correspondence should be addressed. Tel.: 31-20-598-7196; Fax: 31-20-598-7229; E-mail: barbara.bakker{at}falw.vu.nl.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.